Physiological Modeling of Age-Specific Changes in the Pharmacokinetics of Organic Chemicals in Children
- 1 January 2003
- journal article
- research article
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health, Part A
- Vol. 66 (5) , 417-433
- https://doi.org/10.1080/15287390306450
Abstract
Age-specific changes in the pharmacokinetics of chemicals are primarily due to differences in physiological and biochemical factors. For integrating the available information on the age-dependent changes in the physiological and biochemical factors, and for evaluating their combined influence on the pharmacokinetics of chemicals, physiologically based pharmacokinetic (PBPK) models are potentially useful. The objectives of this study were, therefore, (1) to assemble information on age-specific differences in physiological parameters such as alveolar ventilation rate, cardiac output, tissue volumes, tissue blood flow rates, and tissue composition for children of various age groups, and (2) to incorporate these data within a PBPK model for simulating the inhalation pharmacokinetics of a highly metabolized, volatile organic chemical (furan) in children of specific age groups (6, 10, and 14 yr old). The age-specific data on various physiological parameters were assembled following a review of the relevant literature and the hepatic metabolism rate of furan was set equal to the liver blood flow rate in adults and children. The blood:air and tissue:blood partition coefficients were calculated using molecular structure information along with the data on the blood and tissue composition (lipid and water contents) in children and adults. The PBPK model was used to simulate the pharmacokinetics of furan in adults and children (6, 10, and 14 yr old) exposed continuously for 30 h to 1 w g/L of this chemical in inhaled air. The model simulations suggest that, for the same exposure conditions, the blood concentration of furan is likely to be greater in children by a factor of 1.5 (at steady state) than in adults, and the maximal factor of adult-children differences in liver concentration of furan metabolite is about 1.25. The PBPK model framework developed in this study should be useful for predicting the adult-children differences in internal dose of chemicals for risk assessment applications.Keywords
This publication has 20 references indexed in Scilit:
- CHARACTERIZATION OF AGE-RELATED CHANGES IN BODY WEIGHT AND ORGAN WEIGHTS FROM BIRTH TO ADOLESCENCE IN HUMANSJournal of Toxicology and Environmental Health, Part A, 2001
- Chemicals and Children's Environment: What We Don't Know about RisksEnvironmental Health Perspectives, 1998
- A methodology for solving physiologically based pharmacokinetic models without the use of simulation softwaresToxicology Letters, 1996
- Molecular Structure-Based Prediction of the Partition Coefficients of Organic Chemicals for Physiological Pharmacokinetic ModelsToxicology Mechanisms and Methods, 1996
- Pharmacokinetics in the child.Environmental Health Perspectives, 1994
- Echo Doppler assessment of cardiac output and its relation to growth in normal infantsThe American Journal of Cardiology, 1987
- The composition of body tissuesThe British Journal of Radiology, 1986
- Dead space ventilation in normal children and children with obstructive airways diease.Thorax, 1976
- Muscle Blood Flow in Normal Man and in Patients with Intermittent Claudication Evaluated by Simultaneous Xe133 and Na24 Clearances *Journal of Clinical Investigation, 1964
- Pulse Rate, Respiratory Rate, and Body Temperature of Children between Two Months and Eighteen Years of AgeChild Development, 1952